Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Sol-Gel Technologies Ltd. (NASDAQ: SLGL).

Full DD Report for SLGL

You must become a subscriber to view this report.


Recent News from (NASDAQ: SLGL)

Sol-Gel Technologies EPS in-line
Sol-Gel Technologies (NASDAQ: SLGL ): Q1 EPS of -$0.39 in-line. Cash and equivalents of $79.8M. Press Release More news on: Sol-Gel Technologies Ltd., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: May, 15 2018 16:58
Sol-Gel Technologies Reports First Quarter 2018 Financial Results
NESS ZIONA, Israel, May 15, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ:SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for th...
Source: GlobeNewswire
Date: May, 15 2018 16:05
Sol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Website
NESS ZIONA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ:SLGL), a clinical-stage dermatology company, announced today that it filed its Annual Report for 2017 on Form 20-F, containing audited financial statements for the year ended December 31, 2017, as filed...
Source: GlobeNewswire
Date: March, 26 2018 16:05
Sol-Gel Technologies reports FY results
Sol-Gel Technologies (NASDAQ: SLGL ): FY EPS of $5.02 More news on: Sol-Gel Technologies Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: March, 26 2018 07:08
Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results
NESS ZIONA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ:SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for ...
Source: GlobeNewswire
Date: March, 26 2018 07:05
Premarket analyst action - healthcare
Intra-Cellular Therapies (NASDAQ: ITCI ) initiated with Overweight rating and $25 (28% upside) price target at JPMorgan. More news on: Intra-Cellular Therapies Inc., Intec Pharma, Sage Therapeutics, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: February, 26 2018 09:20
Stocks To Watch: Investors Recharge After Soothing Fedspeak
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Stocks look to keep up some momentum as the focus of investor turns back to strong ...
Source: SeekingAlpha
Date: February, 24 2018 09:30
Biotechs Take The Podium With The Year's 3 Best IPOs
Biotechs hold gold, silver and bronze in the 2018 IPO market. Cancer immunotherapy devloper ARMO BioSciences (ARMO) is by far the year's best-performing IPO, up 200% from its offer price. Rounding out the podium are chronic itch biotech Menlo Therapeutics ([[MNLO]]; +105%) and gene thera...
Source: SeekingAlpha
Date: February, 22 2018 05:43
Sol-Gel's Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meeting
NESS ZIONA, Israel, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ:SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, ...
Source: GlobeNewswire
Date: February, 15 2018 16:30
Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
NESS ZIONA, Israel, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ:SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, ...
Source: GlobeNewswire
Date: February, 05 2018 16:01

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-178.859.509.68998.858,108

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-212,9216,08148.0349Short
2018-05-183,5509,01039.4007Short
2018-05-174,6556,71569.3224Short
2018-05-161,9994,38645.5768Short
2018-05-153,0327,68939.4330Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SLGL.


About Sol-Gel Technologies Ltd. (NASDAQ: SLGL)

Logo for Sol-Gel Technologies Ltd. (NASDAQ: SLGL)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: SLGL)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 15 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 17 2018
      Annual and transition report of foreign private issuers under sections 13 or 15(d)
      Filing Type: 20-FFiling Source: edgar
      Filing Date: March, 26 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 26 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 22 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: February, 26 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: February, 26 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: February, 15 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 12 2018
      Filing by person(s) reporting owned shares of common stock in a public company >5%
      Filing Type: SC 13DFiling Source: edgar
      Filing Date: February, 12 2018

       

       


      Daily Technical Chart for (NASDAQ: SLGL)

      Daily Technical Chart for (NASDAQ: SLGL)


      Stay tuned for daily updates and more on (NASDAQ: SLGL)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: SLGL)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      The Subway Trader
      @TheSubwayTrader

       

       


      Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SLGL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of SLGL and does not buy, sell, or trade any shares of SLGL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/